You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Cabazitaxel: a novel second-line treatment for metastatic castration-resistant prostate cancer
|
|---|---|
| Published in |
Drug Design, Development and Therapy, March 2011
|
| DOI | 10.2147/dddt.s13029 |
| Pubmed ID | |
| Authors |
Channing J Paller, Emmanuel S Antonarakis |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| India | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 210 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Switzerland | 1 | <1% |
| Unknown | 209 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 35 | 17% |
| Researcher | 31 | 15% |
| Student > Bachelor | 28 | 13% |
| Student > Master | 27 | 13% |
| Student > Postgraduate | 10 | 5% |
| Other | 31 | 15% |
| Unknown | 48 | 23% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 45 | 21% |
| Agricultural and Biological Sciences | 30 | 14% |
| Biochemistry, Genetics and Molecular Biology | 24 | 11% |
| Chemistry | 15 | 7% |
| Pharmacology, Toxicology and Pharmaceutical Science | 12 | 6% |
| Other | 29 | 14% |
| Unknown | 55 | 26% |
Attention Score in Context
This research output has an Altmetric Attention Score of 21. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 July 2023.
All research outputs
#1,768,851
of 25,728,855 outputs
Outputs from Drug Design, Development and Therapy
#78
of 2,280 outputs
Outputs of similar age
#7,037
of 121,018 outputs
Outputs of similar age from Drug Design, Development and Therapy
#3
of 9 outputs
Altmetric has tracked 25,728,855 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,280 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.3. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 121,018 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 9 others from the same source and published within six weeks on either side of this one. This one has scored higher than 6 of them.